GUELPH, ONTARIO--(Marketwire - March 17, 2010) - Syngenta Crop Protection Canada, Inc. today announced its intent to work with Innovotech (TSX VENTURE:IOT), a Canadian biotechnology product development company, clearing the way for continued research trials in North America on the new plant bacterial blight research product, oxysilver nitrate.
Earlier this year Innovotech and Syngenta entered into a mutually beneficial agreement by which Syngenta will conduct research trials of oxysilver nitrate in a seed treatment application for control of bacterial blight.
"We are very pleased to play a part in the development of this new technology," said Coby Long, North American Seed Care marketing head at Syngenta. "We believe it is important to continually seek out new innovative pest management solutions for producers, both in North America and worldwide."
Bacteria, like fungi, exist in the soil as part of a dynamic agricultural system. Dry beans as well as other crops, can be greatly affected by bacterial diseases. Bacterial blight is a serious problem for many crops with very few acceptable control products available to Canadian producers.
Innovotech is an Edmonton, Alberta-based biotechnology product development company that bases its product line on its unique understanding of biofilms. Currently, Innovotech has products in medical diagnostics and agriculture, and is constantly developing new products or improvements to its existing product lines. For more information please go to www.innovotech.ca.
Syngenta is one of the world's leading companies with more than 25,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.
FOR FURTHER INFORMATION PLEASE CONTACT:
Media contacts:
Syngenta Crop Protection Canada, Inc.
Judy Shaw
Corporate Communications
(519) 837-5328
judy.shaw@syngenta.com
or
Syngenta Crop Protection Canada, Inc.
Norm Dreger
Head, Business Development
(403) 219-5415
norm.dreger@syngenta.com
or
Syngenta Crop Protection Canada, Inc.
140 Research Lane
Guelph, ON N1G 4Z3
+[519] 836-5665
+[519] 836-1032 (FAX)
www.syngenta.ca
or
Innovotech
Ken Boutilier
President
780-448-0585 ext 221
ken.boutilier@innovotech.ca
www.innovotech.ca